AN2 Therapeutics | Investor Presentation Deck

The slide uses a hub-and-spoke diagram to connect Boron to four therapeutic areas (Oncology, Inflammatory Response, Parasites, Bacterial Diseases).present_solution

Open slide detailBeat · Solution

The slide uses a Gantt-style chart to show the development stage of multiple drug candidates.plan_implementation

Open slide detail

The slide uses a timeline-based framework to categorize R&D milestones and market opportunities.plan_implementation

Open slide detail

transition

Open slide detail

The slide combines a problem statement (clinical unmet need) with a market sizing chart.size_opportunity

Open slide detailBeat · Market Size

Includes clinical trial timeline diagram and outcome tables.show_traction

Open slide detailBeat · Market Size

The table uses blue highlighting to emphasize the higher severity metrics in the EBO Ph 2 group.compare_peers

Open slide detailBeat · Traction

LSM = Least squares mean. PRO = Patient-Reported Outcome. The slide highlights alignment with FDA guidance for primary endpoints in NTM trials.show_traction

Open slide detailBeat · Traction

The chart highlights a statistically significant improvement (p=0.036) at month 6.show_traction

Open slide detailBeat · TractionLoop · Voice Of Customer

The chart shows a longitudinal comparison of two treatment groups over 6 months. The p-value of 0.043 indicates nominal statistical significance for the differeanalyze_data

Open slide detailBeat · TractionLoop · Voice Of Customer

The slide presents TEAE (Treatment-emergent adverse events) and SAE (Serious adverse events) data.show_traction

Open slide detailBeat · Traction

Focuses on PRO (Patient Reported Outcomes) as a primary endpoint for the EBO-301 trial.plan_implementation

Open slide detail

The slide presents three line charts (A, B, C) comparing PBS, IMI (Imipenem), and two doses of EBO (EBO25, EBO50) over 4 weeks.show_traction

Open slide detail

transition

Open slide detail

Includes a map showing global distribution and a specific callout for US endemicity.frame_problem

Open slide detailBeat · ProblemLoop · Cost Of Inaction

The slide uses a central hub-and-spoke style diagram to connect funding sources with market potential.size_opportunity

Open slide detailBeat · ProblemLoop · Cost Of Inaction

The chart shows Log10 CFU counts in lungs for various treatment groups compared to untreated control.show_traction

Open slide detailLoop · Cost Of Inaction

The slide uses a dual-track timeline approach to show the progression from observational data collection to clinical trial phases.plan_implementation

Open slide detailLoop · Cost Of Inaction

transition

Open slide detail

Includes a disease progression timeline diagram on the right.frame_problem

Open slide detail

The slide uses a hub-and-spoke diagram to show the global burden relative to specific regions.size_opportunity

Open slide detail

The slide uses a dot map to visualize geographic distribution of infections.size_opportunity

Open slide detail

Includes chemical structure of the benzoxaborole molecule.present_solution

Open slide detail

The chart demonstrates superior efficacy of the lead compound over existing treatments (Benznidazole and E1224) in a model that mirrors human clinical outcomes.show_traction

compare_peers

plan_implementation

transition

The slide uses a hub-and-spoke diagram to connect Boron to various medical fields, with a specific callout to oncology applications.present_solution

Open slide detail

The slide uses a hub-and-spoke diagram to connect the central Boron element to four therapeutic areas, then links to specific development programs.present_solution